Middle East And Africa Radiotherapy Market
![](https://www.blueweaveconsulting.com/assets/front/images/cover-new-3.png)
Middle East and Africa Radiotherapy Market, By Type (External-Beam Radiation Therapy, Internal Radiation Therapy, Systematic Radiotherapy/Radiopharmaceuticals); By Product (External-Beam Radiation Products, Internal Radiation Therapy Products, Radiotherapy Software); By Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer); By End User (Hospitals, Radiation Therapy Center, Specialty Clinics); By Country (Saudi Arabia, UAE, Qatar, Kuwait, South Africa, Nigeria, Algeria, Rest of MEA), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
- Published Date: May 2024
- Report ID: BWC24394
- Available Format: PDF
- Page: 328
Report Overview
An increasing focus by governments and healthcare service providers on the management and treatment of rising prevalence of cancer, governments’ supportive initiatives, and rapid adoption of technological advancements are expected to drive the Middle East and Africa Radiotherapy Market during the forecast period between 2024 and 2030.
Middle East and Africa Radiotherapy Market – Industry Trends & Forecast Report, 2030
The Middle East and Africa Radiotherapy Market size by value was estimated at USD 138.19 million in 2023. During the forecast period between 2024 and 2030, the Middle East and Africa Radiotherapy Market size is projected to grow at a CAGR of 4.75% reaching a value of USD 265.02 million by 2030. Prominent drivers of the Middle East and Africa Radiotherapy Market include the rising incidence of cancer and the expanding utilization of radiotherapy equipment for cancer treatment. This trend is further fueled by a growing preference for non-surgical cancer treatment methods. For instance, data from the National Center for Biotechnology Information indicates that radiotherapy has the potential to enhance cure rates for 3.5 million cancer patients and provide palliative relief for an additional 3.5 million patients annually, amidst a backdrop of over 14 million new cancer cases each year. The increasing incidence of cancer worldwide, coupled with the diverse applications of radiotherapy, is expected to create favorable market opportunities.
Radiotherapy Market – Overview
Radiotherapy is primarily employed to manage tumor growth while minimizing damage to surrounding healthy tissue. It utilizes high-energy radiation, typically x-rays, to eradicate cancer cells and address tumors in various areas of the body, such as the prostate, breast, head & neck, and lungs. Recent advancements in radiotherapy have been notable, driven by enhancements in imaging technologies, robust computer systems, software, and delivery mechanisms, enabling more precise and effective treatment strategies.
Middle East and Africa Radiotherapy Market
Growth Drivers
Rising Prevalence of Cancer
The escalating incidence of cancer globally, particularly in developing regions like Africa, is driving demand for advanced radiotherapy solutions. With annual cancer diagnoses ranging from 3 to 7 million worldwide, and over 50% originating from developing countries, including those in Africa, the urgency to address this growing health concern is paramount. However, the availability of radiotherapy facilities in Africa remains insufficient, with only about 35% of countries possessing such infrastructure. This gap presents opportunities for market growth in the Middle East and Africa (MEA) region. Initiatives to bolster radiotherapy infrastructure, supported by organizations like the International Atomic Energy Agency (IAEA), are essential to meet the rising demand for cancer treatment.
Governments’ Supportive Initiatives
The Middle East and Africa Radiotherapy Market is gaining significant momentum due to the government initiatives. Notably, the WHO's strategic program launched in November 2020 aims at accelerating the eradication of cervical cancer through vaccination, screening, and treatment. In tandem, collaborations like that between the IAEA and WHO issued guidelines in March 2021 to enhance radiotherapy access, particularly in low and middle-income countries. These initiatives, emphasizing equipment selection, utilization, and quality maintenance, align with efforts to increase awareness and adoption of radiotherapy. In the context of the COVID-19 pandemic, African oncology communities have also developed guidelines to manage radiotherapy effectively amidst healthcare system challenges. Such governmental and organizational endeavors are pivotal in propelling the radiotherapy market forward, especially in emerging regions like the Middle East and Africa, with expected significant growth rates.
Challenges
High Cost of Equipment
The Middle East and Africa (MEA) Radiotherapy Market faces a significant hurdle in its growth trajectory due to the high cost of equipment. This financial barrier limits accessibility to advanced radiotherapy solutions for cancer treatment in the region. The expense of acquiring and maintaining radiotherapy equipment poses a challenge for healthcare facilities and governments, hindering their ability to invest in cutting-edge technologies. Consequently, many patients in the MEA region encounter barriers in accessing timely and effective cancer treatment, exacerbating the burden of the disease. Overcoming the challenge of equipment costs is essential to expanding access to radiotherapy and improving cancer care outcomes in the MEA region.
Impact of Geopolitical Tensions on Middle East and Africa Radiotherapy Market
Geopolitical tensions can significantly influence the Middle East and Africa Radiotherapy Market, creating uncertainties that impede market growth. These tensions can disrupt supply chains, hinder investment, and deter international collaborations essential for advancing radiotherapy technologies. Instability and conflict can also divert resources away from healthcare infrastructure development, including radiotherapy facilities. Additionally, geopolitical uncertainties may deter foreign investors and companies from entering the market, limiting access to innovative technologies and expertise. As a result, patients in regions affected by geopolitical tensions may face challenges in accessing timely and quality cancer treatment, exacerbating healthcare disparities and the burden of disease.
Middle East and Africa Radiotherapy Market
Segmental Coverage
Middle East and Africa Radiotherapy Market – By Type
By type, the Middle East and Africa Radiotherapy Market is divided into External-Beam Radiation Therapy, Internal Radiation Therapy, and Systematic Radiotherapy/Radiopharmaceuticals segments. The external-beam radiation therapy segment hods the highest share in the Middle East and Africa Radiotherapy Market by type. External-beam radiation therapy, which delivers high-energy radiation beams externally to target cancer cells, is widely utilized due to its effectiveness in treating various cancer types. Also, advancements in technology have enhanced the precision and efficacy of external-beam radiation therapy, making it a preferred choice among healthcare providers. Notably, the relative affordability and accessibility of external-beam radiation therapy equipment contribute to its prominence in the Middle East and Africa region.
Middle East and Africa Radiotherapy Market – By Product
Based on product, the Middle East and Africa Radiotherapy Market is divided into External-Beam Radiation Products, Internal Radiation Therapy Products, and Radiotherapy Software segments. The external-beam radiation products segment holds the highest share in the Middle East and Africa Radiotherapy Market by product. It is primarily driven by rising demand for devices like LINAC, proton therapy, cyberknife, and gamma knife. These are crucial for treating a spectrum of cancers including breast, lung, prostate, colorectal, lymphoma, liver, thyroid, brain, cervical, and spinal cancers, among others.
Middle East and Africa Radiotherapy Market – By Application
By application, the Middle East and Africa Radiotherapy Market is divided into Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, and Spine Cancer segments. The breast cancer segment holds the highest share in the Middle East and Africa Radiotherapy Market by application. Breast cancer represents a significant health challenge in the region, comprising 34% of new cancer cases and 22% of cancer-related deaths among women in 2020. With new breast cancer cases nearly doubling annually over the past two decades, there's a pressing need for enhanced patient care. The launch of the Policy Report "Improving Breast Cancer in the Middle East and Africa" underscores this urgency, offering insights into breast cancer care across nine MEA countries and aiming to facilitate policy decisions and the exchange of best practices in the region.
Middle East and Africa Radiotherapy Market – By End User
On the basis of end user, the Middle East and Africa Radiotherapy Market is divided into Hospitals, Radiation Therapy Centers, and Specialty Clinics segments. The hospitals segment holds the highest share in the Middle East and Africa Radiotherapy Market by end user. Hospitals serve as primary hubs for cancer treatment, equipped with radiotherapy facilities to cater to patient needs effectively. Given the rising prevalence of cancer in the region, hospitals play a crucial role in providing access to radiotherapy services. Additionally, hospitals often have specialized oncology departments staffed with trained professionals, ensuring comprehensive care for patients undergoing radiotherapy treatment. As a result, the hospitals segment holds the highest share, reflecting their central role in delivering radiotherapy services across the Middle East and Africa.
Middle East and Africa Radiotherapy Market – By Country
The in-depth research report on the Middle East and Africa Radiotherapy Market covers the market in the region’s major countries including Saudi Arabia, UAE, Qatar, Kuwait, South Africa, Nigeria, and Rest of MEA. South Africa holds the highest share in the Middle East and Africa Radiotherapy Market and is expected to maintain its dominance during the forecast period. It is primarily due to significant advancements in cancer treatment infrastructure. For instance, Groote Schuur Hospital's recent investment in state-of-the-art linear accelerator (LINAC) machines, each costing ZAR 47 million, underscores this commitment. These machines enable advanced radiotherapy techniques like volumetric modulated arc therapy and stereotactic body radiotherapy, enhancing treatment precision and patient outcomes. Also, the hospital's focus on comprehensive cancer care, including brachytherapy and orthovoltage treatments, further solidifies South Africa's position as a leader in radiotherapy advancements in the region.
Competitive Landscape
Major players operating in Middle East and Africa Radiotherapy Market include Elekta, Varian Medical Systems, VMCOGULF, Brainlab, GE Healthcare, Philips, Abbott Laboratories, Siemens, Sysmex Corporation, and Accuray. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
Scope of the Report
Attributes |
Details |
Years Considered |
Historical Data – 2019–2030 |
Base Year – 2023 |
|
Estimated Year – 2024 |
|
Forecast Period – 2024–2030 |
|
Facts Covered |
Revenue in USD million |
Market Coverage |
Saudi Arabia, UAE, Qatar, Kuwait, South Africa, Nigeria, Algeria, Rest of MEA |
Product/ Service Segmentation |
Type, Product, Application, End User, Country |
Key Players |
Elekta, Varian Medical Systems, VMCOGULF, Brainlab, GE Healthcare, Philips, Abbott Laboratories, Siemens, Sysmex Corporation, Accuray |
By Type
-
External-Beam Radiation Therapy
-
Internal Radiation Therapy
-
Systematic Radiotherapy/Radiopharmaceuticals
By Product
-
External-Beam Radiation Products
-
Internal Radiation Therapy Products
-
Radiotherapy Software
By Application
-
Breast Cancer
-
Lung Cancer
-
Prostate Cancer
-
Colorectal Cancer
-
Lymphoma
-
Liver Cancer
-
Thyroid Cancer
-
Brain Cancer
-
Cervical Cancer
-
Spine Cancer
By End User
-
Hospitals
-
Radiation Therapy Center
-
Specialty Clinics
By Country
-
Saudi Arabia
-
UAE
-
Qatar
-
Kuwait
-
South Africa
-
Nigeria
-
Algeria
-
Rest of MEA
- Research Framework
- Research Objective
- Product Overview
- Market Segmentation
- Executive Summary
- Middle East and Africa Radiotherapy Market Insights
- Industry Value Chain Analysis
- DROC Analysis
- Growth Drivers
- Rising Prevalence of Cancer
- Government Initiatives
- Increasing Technological Advancements
- Restraints
- High Cost of Equipment
- Shortage of Skilled Professionals
- Limited Reimbursement
- Opportunities
- Telehealth and Remote Training
- Focus on Preventive Care
- Public-Private Partnerships
- Challenges
- Political and Economic Instability
- Fragmented Regulatory Landscape
- Growth Drivers
- Technological Advancements/Recent Developments
- Regulatory Framework
- Porter’s Five Forces Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of New Entrants
- Threat of Substitutes
- Intensity of Rivalry
- Middle East and Africa Radiotherapy Market: Marketing Strategies
- Middle East and Africa Radiotherapy Market Overview
- Market Size & Forecast, 2019–2030
- By Value (USD Million)
- Market Share and Forecast
- By Type
- External-Beam Radiation Therapy
- Internal Radiation Therapy
- Systematic Radiotherapy/Radiopharmaceuticals
- Others
- By Product
- External-Beam Radiation Products
- Internal Radiation Therapy Products
- Radiotherapy Software
- Others
- By Application
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Colorectal Cancer
- Lymphoma
- Liver Cancer
- Thyroid Cancer
- Brain Cancer
- Cervical Cancer
- Spine Cancer
- Others
- By End User
- Hospitals
- Radiation Therapy Center
- Specialty Clinics
- Others
- By Country
- Saudi Arabia
- UAE
- Qatar
- Kuwait
- South Africa
- Nigeria
- Algeria
- Rest of MEA
- By Type
- Market Size & Forecast, 2019–2030
- Saudi Arabia Radiotherapy Market
- Market Size & Forecast, 2019–2030
- Market Share & Forecast
- By Type
- By Product
- By Application
- By End User
- UAE Radiotherapy Market
- Market Size & Forecast, 2019–2030
- By Value (USD Million)
- Market Share & Forecast
- By Type
- By Product
- By Application
- By End User
- Market Size & Forecast, 2019–2030
- Qatar Radiotherapy Market
- Market Size & Forecast, 2019–2030
- By Value (USD Million)
- Market Share & Forecast
- By Type
- By Product
- By Application
- By End User
- Market Size & Forecast, 2019–2030
- Bahrain Radiotherapy Market
- Market Size & Forecast, 2019–2030
- By Value (USD Million)
- Market Share & Forecast
- By Type
- By Product
- By Application
- By End User
- Market Size & Forecast, 2019–2030
- Kuwait Radiotherapy Market
- Market Size & Forecast, 2019–2030
- By Value (USD Million)
- Market Share & Forecast
- By Type
- By Product
- By Application
- By End User
- Market Size & Forecast, 2019–2030
- Oman Radiotherapy Market
- Market Size & Forecast, 2019–2030
- By Value (USD Million)
- Market Share & Forecast
- By Type
- By Product
- By Application
- By End User
- Competitive Landscape
- List of Key Players and Their Offerings
- Middle East and Africa Radiotherapy Market Share Analysis, 2023
- Competitive Benchmarking, By Operating Parameters
- Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
- Impact of Escalating Geopolitical Tensions on Middle East and Africa Radiotherapy Market
- Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
- Elekta
- Varian Medical Systems
- VMCOGULF
- Brainlab
- GE Healthcare
- Philips
- Abbott Laboratories
- Siemens
- Sysmex Corporation
- Accuray
- Other Prominent Players
- Key Strategic Recommendations
- Research Methodology
- Qualitative Research
- Primary & Secondary Research
- Quantitative Research
- Market Breakdown & Data Triangulation
- Secondary Research
- Primary Research
- Breakdown of Primary Research Respondents, By Country
- Assumptions & Limitations
- Qualitative Research
* Financial information of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable
List of Figures
Figure 1 Middle East and Africa Radiotherapy Segmentation
Figure 2 Middle East and Africa Radiotherapy Market Value Chain Analysis
Figure 3 Company Market Share Analysis, 2023
Figure 4 Middle East and Africa Radiotherapy Market Size, By Value (USD Million), 2019–2030
Figure 5 Middle East and Africa Radiotherapy Market Share, By Type, By Value, 2019–2030
Figure 6 Middle East and Africa Radiotherapy Market Share, By Product, By Value, 2019–2030
Figure 7 Middle East and Africa Radiotherapy Market Share, By Application, By Value, 2019–2030
Figure 8 Middle East and Africa Radiotherapy Market Share, By End User, By Value, 2019–2030
Figure 9 Middle East and Africa Radiotherapy Market Share, By Country, By Value, 2019–2030
Figure 10 Saudi Arabia Radiotherapy Market Size, By Value (USD Million), 2019–2030
Figure 11 Saudi Arabia Radiotherapy Market Share, By Type, By Value, 2019–2030
Figure 12 Saudi Arabia Radiotherapy Market Share, By Product, By Value, 2019–2030
Figure 13 Saudi Arabia Radiotherapy Market Share, By Application, By Value, 2019–2030
Figure 14 Saudi Arabia Radiotherapy Market Share, By End User, By Value, 2019–2030
Figure 15 UAE Radiotherapy Market Size, By Value (USD Million), 2019–2030
Figure 16
Figure 17 UAE Radiotherapy Market Share, By Product, By Value, 2019–2030
Figure 18 UAE Radiotherapy Market Share, By Application, By Value, 2019–2030
Figure 19 UAE Radiotherapy Market Share, By End User, By Value, 2019–2030
Figure 20 Qatar Radiotherapy Market Size, By Value (USD Million), 2019–2030
Figure 21 Qatar Radiotherapy Market Share, By Type, By Value, 2019–2030
Figure 22 Qatar Radiotherapy Market Share, By Product, By Value, 2019–2030
Figure 23 Qatar Radiotherapy Market Share, By Application, By Value, 2019–2030
Figure 24 Qatar Radiotherapy Market Share, By End User, By Value, 2019–2030
Figure 25 Bahrain Radiotherapy Market Size, By Value (USD Million), 2019–2030
Figure 26 Bahrain Radiotherapy Market Share, By Type, By Value, 2019–2030
Figure 27 Bahrain Radiotherapy Market Share, By Product, By Value, 2019–2030
Figure 28 Bahrain Radiotherapy Market Share, By Application, By Value, 2019–2030
Figure 29 Bahrain Radiotherapy Market Share, By End User, By Value, 2019–2030
Figure 30 Kuwait Radiotherapy Market Size, By Value (USD Million), 2019–2030
Figure 31 Kuwait Radiotherapy Market Share, By Type, By Value, 2019–2030
Figure 32 Kuwait Radiotherapy Market Share, By Product, By Value, 2019–2030
Figure 33 Kuwait Radiotherapy Market Share, By Application, By Value, 2019–2030
Figure 34 Kuwait Radiotherapy Market Share, By End User, By Value, 2019–2030
Figure 35 Oman Radiotherapy Market Size, By Value (USD Million), 2019–2030
Figure 36 Oman Radiotherapy Market Share, By Type, By Value, 2019–2030
Figure 37 Oman Radiotherapy Market Share, By Product, By Value, 2019–2030
Figure 38 Oman Radiotherapy Market Share, By Application, By Value, 2019–2030
Figure 39 Oman Radiotherapy Market Share, By End User, By Value, 2019–2030
List of Tables
Table 1 Middle East and Africa Radiotherapy Market Size, By Value (USD Million), 2019–2030
Table 2 Middle East and Africa Radiotherapy Market Size, By Type, By Value, 2019–2030
Table 3 Middle East and Africa Radiotherapy Market Size, By Product, By Value, 2019–2030
Table 4 Middle East and Africa Radiotherapy Market Size, By Application, By Value, 2019–2030
Table 5 Middle East and Africa Radiotherapy Market Size, By End User, By Value, 2019–2030
Table 6 Middle East and Africa Radiotherapy Market Size, By Country, By Value, 2019–2030
Table 7 Saudi Arabia Radiotherapy Market Size, By Value (USD Million), 2019–2030
Table 8 Saudi Arabia Radiotherapy Market Size, By Type, By Value, 2019–2030
Table 9 Saudi Arabia Radiotherapy Market Size, By Product, By Value, 2019–2030
Table 10 Saudi Arabia Radiotherapy Market Size, By Application, By Value, 2019–2030
Table 11 Saudi Arabia Radiotherapy Market Size, By End User, By Value, 2019–2030
Table 12 UAE Radiotherapy Market Size, By Value (USD Million), 2019–2030
Table 13 UAE Radiotherapy Market Size, By Type, By Value, 2019–2030
Table 14 UAE Radiotherapy Market Size, By Product, By Value, 2019–2030
Table 15 UAE Radiotherapy Market Size, By Application, By Value, 2019–2030
Table 16 UAE Radiotherapy Market Size, By End User, By Value, 2019–2030
Table 17 Qatar Radiotherapy Market Size, By Value (USD Million), 2019–2030
Table 18 Qatar Radiotherapy Market Size, By Type, By Value, 2019–2030
Table 19 Qatar Radiotherapy Market Size, By Product, By Value, 2019–2030
Table 20 Qatar Radiotherapy Market Size, By Application, By Value, 2019–2030
Table 21 Qatar Radiotherapy Market Size, By End User, By Value, 2019–2030
Table 22 Bahrain Radiotherapy Market Size, By Value (USD Million), 2019–2030
Table 23 Bahrain Radiotherapy Market Size, By Type, By Value, 2019–2030
Table 24 Bahrain Radiotherapy Market Size, By Product, By Value, 2019–2030
Table 25 Bahrain Radiotherapy Market Size, By Application, By Value, 2019–2030
Table 26 Bahrain Radiotherapy Market Size, By End User, By Value, 2019–2030
Table 27 Kuwait Radiotherapy Market Size, By Value (USD Million), 2019–2030
Table 28 Kuwait Radiotherapy Market Size, By Type, By Value, 2019–2030
Table 29 Kuwait Radiotherapy Market Size, By Product, By Value, 2019–2030
Table 30 Kuwait Radiotherapy Market Size, By Application, By Value, 2019–2030
Table 31 Kuwait Radiotherapy Market Size, By End User, By Value, 2019–2030
Table 32 Oman Radiotherapy Market Size, By Value (USD Million), 2019–2030
Table 33 Oman Radiotherapy Market Size, By Type, By Value, 2019–2030
Table 34 Oman Radiotherapy Market Size, By Product, By Value, 2019–2030
Table 35 Oman Radiotherapy Market Size, By Application, By Value, 2019–2030
Table 36 Oman Radiotherapy Market Size, By End User, By Value, 2019–2030
Table 37 Elekta Company Overview
Table 38 Elekta Financial Overview
Table 39 Varian Medical Systems Company Overview
Table 40 Varian Medical Systems Financial Overview
Table 41 VMCOGULF Company Overview
Table 42 VMCOGULF Financial Overview
Table 43 Brainlab Company Overview
Table 44 Brainlab Financial Overview
Table 45 GE Healthcare Company Overview
Table 46 GE Healthcare Financial Overview
Table 47 Philips Company Overview
Table 48 Philips Financial Overview
Table 49 Abbott Laboratories Company Overview
Table 50 Abbott Laboratories Financial Overview
Table 51 Sysmex Corporation Company Overview
Table 52 Sysmex Corporation Financial Overview
Table 53 Siemens Company Overview
Table 54 Siemens Financial Overview
Table 53 Other Prominent Players Company Overview
Table 54 Other Prominent Players Financial Overview
Market Segmentation
To request a free sample copy of this report, please complete the form below.
We value your investment and offer free customization with every report to fulfil your exact research needs.
Frequently Asked Questions (FAQs):
RELATED REPORTS
WHY CHOOSE US
-
24/7 Research Support
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
-
Custom Research Service
Ask the Analyst to customize an exclusive study to serve your research needs
-
Quality & Accuracy
Ask the Analyst to customize an exclusive study to serve your research needs
-
Data Visualization
As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
-
Information security
We never share your personal and confidential information. Your personal information is safe and secure with us.